Related Experiment Videos
[Fibronectin levels in threatened abortion]
S Woźniak1, R Sikorski, B Wójcicka-Bartłomiejczyk
1Kliniki Ginekologii II Katedry Połoznictwa i Chorób Kobiecych Akademii Medycznej w Lublinie.
Ginekologia Polska
|May 4, 1999
Summary
Women experiencing threatened abortion (TA) show higher plasma fibronectin (pFN) and fetal fibronectin (fFN) levels. These fibronectin levels increase further with vaginal bleeding or trophoblast presence in TA cases.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Biology
- Biochemistry
Background:
- Fibronectin is a glycoprotein crucial for cell adhesion and tissue repair.
- Altered fibronectin levels are implicated in various pregnancy complications.
- Early detection of threatened abortion is vital for timely intervention.
Purpose of the Study:
- To investigate plasma fibronectin (pFN) and fetal fibronectin (fFN) levels in women with threatened abortion (TA).
- To correlate fibronectin levels with clinical signs of threatened abortion, such as vaginal bleeding and trophoblast presence.
Main Methods:
- Assay of plasma fibronectin (pFN) in maternal blood serum.
- Quantification of fetal fibronectin (fFN) in cervico-vaginal secretions.
- Comparison of fibronectin levels between healthy pregnant women and those with threatened abortion.
Main Results:
- Significantly elevated levels of both pFN and fFN were observed in women with threatened abortion compared to healthy controls.
- Within the threatened abortion group, vaginal bleeding and/or trophoblast presence were associated with further significant increases in fibronectin levels.
Conclusions:
- Elevated maternal plasma and fetal cervico-vaginal fibronectin may serve as biomarkers for threatened abortion.
- Fibronectin levels show a positive correlation with the severity of threatened abortion symptoms.